All articles — 4987 total
Eastfield Resources heads into the end of April with a sharp single-day drop and shorts continuing to unwind — a pairing that tells two distinct stories at once. The stock fell 18% on April 29 to close at C$0.045. That…
ATEX Resources shares fell 12.3% this week to CAD $3.06 — giving up nearly all of a strong month that had gained 2.7% — as the broader gold and copper developer space hit an air pocket, leaving investors weighing two…
EBMT enters the week after a clean Q1 earnings beat — and the market's reaction has pushed the stock to its best level in months. Q1 results, reported April 28, came in at $0.51 per diluted share, beating the consensus…
EGBN heads into the end of April with short sellers sitting tight despite a weak post-earnings week — and the options market signalling the most bullish relative read in months. Short interest has been a persistent…
EOG Resources heads into its May 6 Q1 earnings call with short sellers actively cutting positions and the stock recovering from a rough April. The most notable move this week is the rapid pullback in bearish…
E enters the final session of April with a quietly charged setup: short interest is climbing at its fastest weekly pace in months, options positioning has turned unusually defensive, and the borrow market has…
E-L Financial Corporation Limited enters its Q1 2026 results on May 7 with the most striking story sitting not in its positioning but in a dramatic unwind of what had been an unusually expensive borrow. The lending…
EDPF.Y — the OTC-traded ADR of Portuguese utility EDP, S.A. — enters its May 7 earnings release with a striking split in its lending market: short positions have collapsed to a fraction of their April peak, yet the…
EDAP TMS goes into its Q1 2026 earnings call on May 7 carrying a month of losses and a freshly cut analyst target — with options traders, unusually, leaning the other way. The most pressing backdrop is the price. EDAP…
DMC Global reports Q1 results today with the stock up 11% on the week — a sharp reversal of fortune for a name that was shellacked after its last print. The February earnings release was severe by any measure. The…
Dycom Industries enters its May 20 earnings window with shorts rebuilding sharply and options traders tilting bullish — an unusual divergence worth watching in a stock that has fallen twice in a row on results…
Dundee Corporation heads into May with the week's most prominent story sitting firmly in the ownership register, not the borrow market. Pointillist Capital Management, a 10% owner, has been running a sustained exit…
Ducommun heads into its May 7 Q1 print carrying the sharpest short-interest build the stock has seen in months, set against a Street that has just lifted its targets and a price that — despite a 14.6% monthly gain —…
EVI Industries has shed 12% over the past week to $18.20, testing lows not seen since well before the autumn peak of nearly $30. The stock's decline has been the defining feature this week. EVI fell 12.3% in seven…
Donaldson Company heads into its June earnings window with short sellers adding positions at the fastest pace in months and insiders heading for the exit. Short interest has been the defining feature of this week's…
Dominion Energy heads into Thursday's Q1 earnings with shorts retreating, analyst targets creeping higher, and a dividend score that ranks among the best in the market — the question is whether the results confirm the…
Dr. Reddy's Laboratories received one of its most anticipated regulatory wins in years on Tuesday — Health Canada approved its generic semaglutide injection, making it the first generic version of Novo Nordisk's…
Gulf Resources, Inc. has entered the week under acute regulatory pressure — a Nasdaq noncompliance notice, a 35% single-week collapse in share price, and a compliance deadline running to October. The story here is the…
DIS closes out the week at $101.30, down 3.4% over five sessions, as a confluence of regulatory noise, a reshuffled ESPN strategy, and a Q2 earnings print scheduled for May 6 keeps the stock in the spotlight. The real…
Windtree Therapeutics has more than doubled in price over the past month — yet shorts have almost entirely stepped aside, leaving a volatile micro-cap with little structural pressure in either direction. The price move…
